{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:02:59Z","timestamp":1761512579449,"version":"build-2065373602"},"reference-count":35,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2009,3,1]],"date-time":"2009-03-01T00:00:00Z","timestamp":1235865600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,3,1]],"date-time":"2009-03-01T00:00:00Z","timestamp":1235865600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,8,22]],"date-time":"2013-08-22T00:00:00Z","timestamp":1377129600000},"content-version":"vor","delay-in-days":1635,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","seizure-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seizure"],"published-print":{"date-parts":[[2009,3]]},"DOI":"10.1016\/j.seizure.2008.07.007","type":"journal-article","created":{"date-parts":[[2008,8,29]],"date-time":"2008-08-29T10:18:03Z","timestamp":1220005083000},"page":"119-123","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Retention of new AEDs in institutionalized intellectually disabled patients with epilepsy"],"prefix":"10.1016","volume":"18","author":[{"given":"J.A.","family":"Carpay","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Aalbers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.A.","family":"Graveland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Engelsman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Suppl 1","key":"10.1016\/j.seizure.2008.07.007_bib1","first-page":"1","article-title":"Epilepsy and mental retardation: an overview","volume":"98","author":"Coulter","year":"1993","journal-title":"Am J Ment Retard"},{"issue":"Suppl 1","key":"10.1016\/j.seizure.2008.07.007_bib2","doi-asserted-by":"crossref","first-page":"S38","DOI":"10.1177\/0883073897012001091","article-title":"Meeting the challenge of epilepsy in persons with multiple handicaps","volume":"12","author":"Sunder","year":"1997","journal-title":"J Child Neurol"},{"key":"10.1016\/j.seizure.2008.07.007_bib3","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1002\/1098-2779(2000)6:4<309::AID-MRDD10>3.0.CO;2-I","article-title":"Treatment of epilepsy in the multiply handicapped","volume":"6","author":"Pellock","year":"2000","journal-title":"Ment Retard Dev Disabil"},{"issue":"Suppl 4","key":"10.1016\/j.seizure.2008.07.007_bib4","first-page":"S24","article-title":"Comprehensive management of epilepsy in persons with mental retardation","volume":"38","author":"Coulter","year":"1997","journal-title":"Epilepsia"},{"issue":"Suppl 6","key":"10.1016\/j.seizure.2008.07.007_bib5","first-page":"S45","article-title":"The role of the old and the new antiepileptic drugs in special populations: mental and multiple handicaps.","volume":"37","author":"Mattson","year":"1996","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2008.07.007_bib6","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1053\/seiz.2001.0528","article-title":"Clinical guidelines for the management of epilepsy in adults with an intellectual disability.","volume":"10","author":"Anonymous","year":"2001","journal-title":"Seizure"},{"key":"10.1016\/j.seizure.2008.07.007_bib7","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1192\/bjp.155.4.522","article-title":"Clinical and therapeutic monitoring of epilepsy in a mental handicap unit","volume":"155","author":"Collacott","year":"1989","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.seizure.2008.07.007_bib8","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/0920-1211(90)90079-B","article-title":"Epilepsy in a population of mentally retarded children and adults","volume":"6","author":"Forsgren","year":"1990","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.seizure.2008.07.007_bib9","first-page":"CD005399","article-title":"Pharmacological interventions for epilepsy in people with intellectual disabilities","author":"Beavis","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.seizure.2008.07.007_bib10","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/S1525-5050(03)00117-3","article-title":"Lamotrigine as adjunctive therapy in patients with refractory epilepsy and mental retardation","volume":"4","author":"McKee","year":"2003","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.seizure.2008.07.007_bib11","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1177\/08830738060210051401","article-title":"Adjunctive lamotrigine for refractory epilepsy in adolescents with mental retardation","volume":"21","author":"McKee","year":"2006","journal-title":"J Child Neurol"},{"key":"10.1016\/j.seizure.2008.07.007_bib12","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1185\/030079906X96281","article-title":"Efficacy and tolerability of adjunctive lamotrigine for refractory epilepsy in institutional or community residents with mental retardation","volume":"22","author":"Sunder","year":"2006","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.seizure.2008.07.007_bib13","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1053\/seiz.1999.0372","article-title":"Efficacy of lamotrigine in institutionalized, developmentally disabled patients with epilepsy: a retrospective evaluation","volume":"9","author":"Gidal","year":"2000","journal-title":"Seizure"},{"key":"10.1016\/j.seizure.2008.07.007_bib14","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/j.yebeh.2004.07.009","article-title":"Levetiracetam for people with mental retardation and refractory epilepsy","volume":"5","author":"Kelly","year":"2004","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.seizure.2008.07.007_bib15","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.yebeh.2003.12.005","article-title":"Levetiracetam in adult patients with and without learning disability: focus on behavioral adverse effects","volume":"5","author":"Brodtkorb","year":"2004","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.seizure.2008.07.007_bib16","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/j.1365-2788.2005.00637.x","article-title":"Topiramate in long-term treatment of epilepsy in the intellectually disabled","volume":"49","author":"Arvio","year":"2005","journal-title":"J Intellect Disabil Res"},{"key":"10.1016\/j.seizure.2008.07.007_bib17","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1053\/seiz.2001.0571","article-title":"Role of topiramate in adults with intractable epilepsy, mental retardation, and developmental disabilities","volume":"11","author":"Singh","year":"2002","journal-title":"Seizure"},{"key":"10.1016\/j.seizure.2008.07.007_bib18","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1007\/s00115-002-1294-3","article-title":"Effekte von Topiramat bei Patienten mit Epilepsie und intellektueller Beeintr\u00e4chtigung [Effects of topiramate in patients with epilepsy and intellectual impairment]","volume":"73","author":"Huber","year":"2002","journal-title":"Nervenartz"},{"key":"10.1016\/j.seizure.2008.07.007_bib19","first-page":"57","article-title":"Gabapentin in the treatment of refractory partial epilepsy in children with intellectual disability","volume":"42","author":"Mikati","year":"1998","journal-title":"J Intellect Disabil Res"},{"key":"10.1016\/j.seizure.2008.07.007_bib20","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S1059-1311(00)90474-6","article-title":"A randomized open-label study of gabapentin and lamotrigine in adults with learning disability and resistant epilepsy","volume":"10","author":"Crawford","year":"2001","journal-title":"Seizure"},{"key":"10.1016\/j.seizure.2008.07.007_bib21","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S1059-1311(97)80066-0","article-title":"A naturalistic study of the use of vigabatrin, lamotrigine and gabapentin in adults with learning disabilities","volume":"6","author":"Bhaumik","year":"1997","journal-title":"Seizure"},{"key":"10.1016\/j.seizure.2008.07.007_bib22","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.yebeh.2006.12.005","article-title":"Long-term retention rates of new antiepileptic drugs in adults with chronic epilepsy and learning disability","volume":"10","author":"Simister","year":"2007","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.seizure.2008.07.007_bib23","unstructured":"Nederlandse Vereniging voor Neurologie, Commissie Kwaliteitsbevordering, Werkgroep Richtlijnen Epilepsie. Richtlijnen Diagnostiek en Behandeling van Epilepsie, Versie; februari 2001 [Dutch Society for Neurology, Commission for Enhancement of Quality, Working Group Guidelines Epilepsy. Guidelines for diagnostics and treatment of epilepsy, version; February 2001]."},{"key":"10.1016\/j.seizure.2008.07.007_bib24","unstructured":"Nederlandse Vereniging voor Neurologie, Werkgroep Richtlijnen Epilepsie. Richtlijnen Diagnostiek en Behandeling van Epilepsie, Herziene, tweede versie; januari 2006 [Dutch Society for Neurology, Commission for Enhancement of Quality, Working Group Guidelines Epilepsy. Guidelines for diagnostics and treatment of epilepsy, revised, second version; January 2006]."},{"key":"10.1016\/j.seizure.2008.07.007_bib25","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/S1059-1311(03)00101-8","article-title":"Limited efficacy of gabapentin in severe therapy-resistant epilepsies of learning-disabled patients","volume":"12","author":"Huber","year":"2003","journal-title":"Seizure"},{"key":"10.1016\/j.seizure.2008.07.007_bib26","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/j.1600-0404.2006.00705.x","article-title":"Comparison of the efficacy and tolerability of new antiepileptic drugs: what can we lean from long-term studies?","volume":"114","author":"Zaccara","year":"2006","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.seizure.2008.07.007_bib27","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1111\/j.1528-1157.2000.tb00165.x","article-title":"Long-term retention rates of lamotrigine, gabapentin, and topiramate in chronic epilepsy","volume":"41","author":"Lhatoo","year":"2000","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2008.07.007_bib28","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.yebeh.2004.03.002","article-title":"Topiramate in clinical practice: long-term experience in patients with refractory epilepsy referred to a tertiary epilepsy center","volume":"5","author":"Bootsma","year":"2004","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.seizure.2008.07.007_bib29","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1111\/j.1528-1157.2000.tb00165.x","article-title":"Prognostic factors affecting long-term retention of topiramate in patients with chronic epilepsy","volume":"41","author":"Lhatoo","year":"2000","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2008.07.007_bib30","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1212\/WNL.56.12.1772","article-title":"Long-term continuation of levetiracetam in patients with refractory epilepsy","volume":"56","author":"Krakow","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.seizure.2008.07.007_bib31","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1136\/jnnp.2005.064626","article-title":"The long-term retention of levetiracetam in a large cohort of patients with epilepsy","volume":"77","author":"Depondt","year":"2006","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.seizure.2008.07.007_bib32","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.seizure.2007.01.004","article-title":"Comparative retention rates and long-term tolerability of new antiepileptic drugs","volume":"16","author":"Chung","year":"2007","journal-title":"Seizure"},{"key":"10.1016\/j.seizure.2008.07.007_bib33","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.yebeh.2007.10.004","article-title":"Lamotrigine in clinical practice: long-term experience in patients with refractory epilepsy referred to a tertiary epilepsy center","volume":"12","author":"Bootsma","year":"2008","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.seizure.2008.07.007_bib34","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.seizure.2007.05.019","article-title":"Long-term effects of levetiracetam and topiramate in clinical practice: a head-to-head comparison","volume":"17","author":"Bootsma","year":"2008","journal-title":"Seizures"},{"key":"10.1016\/j.seizure.2008.07.007_bib35","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/j.1600-0404.2005.00505.x","article-title":"New antiepileptic drugs in practice: how do they perform in the real world?","volume":"181","author":"Sander","year":"2005","journal-title":"Acta Neurol Scand"}],"container-title":["Seizure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1059131108001520?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1059131108001520?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T01:36:55Z","timestamp":1761010615000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1059131108001520"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,3]]},"references-count":35,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009,3]]}},"alternative-id":["S1059131108001520"],"URL":"https:\/\/doi.org\/10.1016\/j.seizure.2008.07.007","relation":{},"ISSN":["1059-1311"],"issn-type":[{"type":"print","value":"1059-1311"}],"subject":[],"published":{"date-parts":[[2009,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Retention of new AEDs in institutionalized intellectually disabled patients with epilepsy","name":"articletitle","label":"Article Title"},{"value":"Seizure","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.seizure.2008.07.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}